[Molecular targeting therapy for chronic myelogenous leukemia].

Authors :: Ono R
Source :: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine [Nihon Naika Gakkai Zasshi] 2003 May 10; Vol. 92 (5), pp. 884-9.
Publication Year :: 2003

Subjects :: Animals
Benzamides
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Fusion Proteins, bcr-abl
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Philadelphia Chromosome
Piperazines
Protein-Tyrosine Kinases antagonists & inhibitors
Pyrimidines adverse effects
Gene Targeting
Genetic Therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive therapy
Pyrimidines therapeutic use

Language :: Japanese
ISSN :: 0021-5384
Volume :: 92
Issue :: 5
Database :: MEDLINE
Journal :: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Publication Type :: Academic Journal
Accession number :: 12808916